AARD insider buying and SEC filings, explained
Aardvark Therapeutics, Inc. · CIK 1774857
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$145K
Insiders who bought
2
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$395K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 10–11, 2026 | Planned (10b5-1) | Nelson Sun (CFO) sold 76,754 shares between Sep 10 and Sep 11 at about $5.15 ($395K), marked as a 10b5-1 plan trade. Holdings down 68% to 35,475 shares. | SEC filing Filed Sep 11, 2026 |
| Dec 11, 2025 | Purchase (code P) | Nelson Sun (CFO) bought 3,000 shares at $14.40 ($43K), reported as a purchase (code P). Holdings up 3% to 108,484 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 12, 2025 |
| Dec 11, 2025 | Purchase (code P) | Tien-Li Lee (CEO and Director) bought 7,000 shares at $14.49 ($101K), reported as a purchase (code P). Holdings up <1% to 1,551,613 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 12, 2025 |
8 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
2 insiders bought in 30 days
$145K in purchases since Dec 11, 2025 · Purchases traded Dec 11, 2025 to Dec 11, 2025 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Tien-Li Lee (CEO) | $101K | Dec 11, 2025 | SEC filing |
| Nelson Sun (CFO) | $43K | Dec 11, 2025 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow AARD in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.